Mr. Abiodun Adenuga Adefarasin, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20746 Mack Avenue, Gross Pointe Woods, MI 48236 Phone: 313-640-9766 Fax: 313-640-9768 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France.
SCOLR Pharma, Inc. today announced that it has signed an agreement with The Emerson Group to provide sales support for the Company's new line of extended-release nutritional and over-the-counter drug products.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.
Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.
The American College of Allergy, Asthma and Immunology (ACAAI) recognizes Teva Respiratory for its continued leadership and support of important educational issues related to respiratory health, particularly under diagnosed and poorly managed asthma and exercise-induced bronchoconstriction. ACAAI announced today that they will partner again this year with Teva Respiratory to bring free asthma screenings to communities nationwide.
› Verified 5 days ago